AzTrials
AzTrials

Social Anxiety DisorderNCT02360033

Systemic Therapy and Cognitive Behavioral Therapy for Social Anxiety Disorders

A study testing Systemic Therapy for Social Anxiety Disorder and Cognitive Behavioral Therapy for Social Anxiety Disorder in people with Social Anxiety Disorder, run by Heidelberg University at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Goals of the study: Systemic Therapy was approved in 2008 by the Scientific Advisory Board on Psychotherapy (Wissenschaftlicher Beirat Psychotherapie: WBP) for a variety of disorders which, at the time, did not include anxiety disorders. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Social Anxiety Disorder
What is being tested?
Systemic Therapy for Social Anxiety Disorder and Cognitive Behavioral Therapy for Social Anxiety Disorder
Could I receive a placebo?
No, everyone receives an active treatment
How many people
38 participants
Where
1 siteGermany
Study dates
Jan 2015to Sep 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Social Anxiety Disorder (SKID: ICD-Diagnosis: F40.1, Liebowitz Social Anxiety Scale > 30);
  • Agreement to participate in the study and to be randomized into the two treatment groups

Who cannot join

  • Acute drug or alcohol intoxication or dependency
  • Anorexia with BMI < 14
  • Psychotic disorder
  • Severe physical diseases

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Institute of Medical Psychology, University Hospital Heidelberg

    Heidelberg, Baden-Wurttemberg, 69115

Other trials in Germany

About this study

Official title: Systemic Therapy and Cognitive Behavioral Therapy for Social Anxiety Disorders With Adults: Manual Development and Randomized-Controled Feasibility Study

Goals of the study:

Systemic Therapy was approved in 2008 by the Scientific Advisory Board on Psychotherapy (Wissenschaftlicher Beirat Psychotherapie: WBP) for a variety of disorders which, at the time, did not include anxiety disorders. According to the 2007 joint methods paper of the WBP and the Mutual Federal Committee (Gemeinsamen Bundesausschuss: G-Ba), there must be three randomized-controlled trials (RCT) for anxiety disorders. These studies are available now but lack explicit details about the clinical significance of the reductions they show in social anxiety symptoms. This project is funded by the German Association for Systemic Therapy, Counseling and Family Therapy (Deutsche Gesellschaft für Systemische Therapie, Beratung und Familientherapie: DGSF).

Read more

Study design:

The study is planned as a mono-centric, balanced pilot RCT. It investigates the feasibility of an RCT comparing Systemic Therapy and Cognitive Behavioral Therapy for Social Anxiety Disorders (SAD) in 32 patients.

Being tested
Systemic Therapy for Social Anxiety Disorder, Cognitive Behavioral Therapy for Social Anxiety Disorder
Medical subject headings
Phobia, Social

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Systemic Therapy for Social Anxiety DisorderBehavioural

  • Cognitive Behavioral Therapy for Social Anxiety DisorderBehavioural

Study groups in NCT02360033
Study groupRoleWhat they receive
Systemic TherapyExperimentalSystemic Therapy deals with the experience in private social systems (e.g. couples. Family, friends) and organizational systems (e.g. work teams), their appraisals and the attitude of the members towards each other within the system. It is analyzed how these systems can lead to the development and maintenance of psychological disorders.
Receives: Behavioral: Systemic Therapy for Social Anxiety Disorder
Cognitive Behavioral TherapyExperimentalCognitive Behavioral Therapy deals with individual behavior as well as individual attitude, thoughts, appraisals and beliefs, which can have an influence on the development and maintenance of psychological disorders.
Receives: Behavioral: Cognitive Behavioral Therapy for Social Anxiety Disorder

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change of Liebowitz Social Anxiety Scale (LSAS-SR)

    Social Anxiety will be assessed using the Liebowitz Social Anxiety Scale (LSAS-SR) in its German version. The LSAS-SR is a brief 24-item self report instrument with 13 items relating to performance anxiety and 11 concerning social situations. Its purpose is to assess the range of social interaction and performance situations feared and the degree of avoidance by a patient in order to assist in the diagnosis of social anxiety disorder, 24 items, German version

    Measured: Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization

  2. Change of Social Interaction Anxiety Scale (SIAS)

    Measure of social interaction anxiety, 20 items, German version

    Measured: Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization

  3. Change of Social Phobia Scale (SPS)

    Measure of anxiety while being observed by others, 20 items, German version

    Measured: Baseline, 8th,15th and 20th hour of therapy, end of treatment; 6, 9 and 12 months after randomization

Secondary outcomes (10)
  1. Change of Adjustment to Symptomatology Scale (ASS)

    Measure of adjustment to the symptomatology, 5 items, German version

    Measured: Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization

  2. Change of Evaluation of Social Systems (EVOS)

    Measure of social relationships in different social systems, 10 items, German version

    Measured: Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization

  3. Change of Experience in Social Systems (EXIS)

    Measure of the individual experience in different social systems, 24 items, German version

    Measured: Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization

  4. Change of Beck Depression Inventory-II (BDI-II)

    Severity of depressive symptoms "at that moment", specifically assessing the intensity of depression in psychiatric and normal populations, 21 items, German version

    Measured: Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization

  5. Change of Brief Symptom Checklist (BSCL)

    The instrument provides an overview of a patient's symptoms and their intensity at a specific point in time, 53 items, German version

    Measured: Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization

  6. Change of Inventory of Interpersonal Problems (IIP-32)

    The IIP-32 is a self-report instrument that identifies a person's most salient interpersonal difficulties. It is a short version of the Inventory of Interpersonal Problems, 32 items, German version

    Measured: Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization

  7. Change of Dyadic Adjustment Scale (DAS-12)

    Measure of relationship adjustment, 12 items, German version

    Measured: Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization

  8. Change of University of Rhode Island Change Assessment (URICA-S, short version)

    Measure of stages of change, 16 items, German version

    Measured: Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization

  9. Change of Burden Assessment Scale (BAS)

    Measure of perceived burden in daily life among resource persons, 19 items, German version

    Measured: Baseline, 26th hour of therapy; 12 months after randomization

  10. Change of Scale for the Multiperspective Assessment of General Change Mechanisms in Psychotherapy (SACiP),

    Measure of the six dimensions of resource activation, problem actuation, mastery, clarification of meaning, emotional bond, agreement on collaboration, 21 items, German version

    Measured: 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Feb 2015 (estimated)
  2. Study startJan 2015
  3. Primary completionJan 2017
  4. Study completionSep 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
38 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02360033
Sponsor's protocol ID
SOPHO-PT-2014
Status last verified
Oct 2019
First submitted
21 Jan 2015
Last updated
18 Oct 2019
Results posted
No
Data monitoring committee
No

Publications

  • Hunger C, Hilzinger R, Koch T, Mander J, Sander A, Bents H, Schweitzer J. Comparing systemic therapy and cognitive behavioral therapy for social anxiety disorders: study protocol for a randomized controlled pilot trial. Trials. 2016 Mar 31;17:171. doi: 10.1186/s13063-016-1252-1.

    PubMed 27029546

Questions about this trial

What is this clinical trial studying?

A study testing Systemic Therapy for Social Anxiety Disorder and Cognitive Behavioral Therapy for Social Anxiety Disorder in people with Social Anxiety Disorder, run by Heidelberg University at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Oct 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change of Liebowitz Social Anxiety Scale (LSAS-SR) (time frame: Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02360033, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Oct 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in